search

Active clinical trials for "Neuroblastoma"

Results 371-380 of 555

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid...

Recurrent NeuroblastomaUnspecified Childhood Solid Tumor1 more

This phase I trial is studying the side effects and best dose of decitabine when given together with doxorubicin and cyclophosphamide in treating children with relapsed or refractory solid tumors or neuroblastoma. Drugs used in chemotherapy, such as decitabine, doxorubicin, and cyclophosphamide, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Completed62 enrollment criteria

Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy

Neuroblastoma

PRIMARY OBJECTIVE To determine the percentage of patients with high risk neuroblastoma in first or subsequent partial response or better, or with microscopic residual bone marrow disease, who demonstrate an immunological anti-tumor response at any time during, and for up to 12 months from initiation of, treatment with subcutaneous injections of autologous neuroblastoma cells, genetically modified by adenoviral vectors to secrete interleukin-2 (IL-2) (autologous neuroblastoma vaccine) SECONDARY OBJECTIVES 1. To determine the toxicity of the autologous neuroblastoma vaccine given according to this schedule 2. To obtain preliminary data on the effect of vaccine administration on progression-free survival from high-risk neuroblastoma

Completed15 enrollment criteria

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Brain and Central Nervous System TumorsGastrointestinal Carcinoid Tumor6 more

RATIONALE: Radiolabeled octreotide can locate tumor cells and deliver radioactive tumor-killing substances to them without harming normal cells. PURPOSE: This phase I trial is to study the safety and effectiveness of radiolabeled octreotide in treating children who have advanced or refractory solid tumors.

Completed67 enrollment criteria

Multiple Therapies in Treating Patients With Advanced Neuroblastoma

Neuroblastoma

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Biological therapies use different ways to stimulate the immune system and stop cancer cell from growing. Combining different types of therapies may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining chemotherapy, monoclonal antibody therapy, surgery, peripheral stem cell transplantation, radiation therapy, and biological therapy in treating patients who have advanced neuroblastoma.

Completed37 enrollment criteria

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Breast CancerChronic Myeloproliferative Disorders9 more

RATIONALE: Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-12 in treating patients who have hematologic cancer or solid tumor.

Completed3 enrollment criteria

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients...

Breast CancerChronic Myeloproliferative Disorders10 more

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining chemotherapy and peripheral stem cell transplantation with biological therapy may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of biological therapy with sargramostim, interleukin-2, and interferon alfa following chemotherapy and peripheral stem cell transplantation in treating patients who have cancer.

Completed37 enrollment criteria

Docetaxel in Treating Children With Recurrent Solid Tumors

Brain and Central Nervous System TumorsNeuroblastoma1 more

Phase II trial to study the effectiveness of docetaxel in treating children with recurrent solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Completed38 enrollment criteria

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain...

Brain TumorsCentral Nervous System Tumors2 more

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctors to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating infants with malignant brain or spinal cord tumors.

Completed48 enrollment criteria

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

Brain and Central Nervous System TumorsChildhood Germ Cell Tumor8 more

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining temozolomide and O6-benzylguanine in treating children who have solid tumors that have not responded to previous therapy.

Completed65 enrollment criteria

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement...

Localized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma3 more

This randomized phase III trial is studying cyclophosphamide, prednisone, and immunoglobulin to see how well they work compared to cyclophosphamide and prednisone alone in treating patients with abnormal trunk muscle movements associated with neuroblastoma. Drugs used in chemotherapy, work in different ways to stop tumor cells from dividing so they stop growing or die. Steroid therapy decreases inflammation. Combining chemotherapy and steroid therapy with immunoglobulin may be effective in treating abnormal muscle movement associated with neuroblastoma.

Completed21 enrollment criteria
1...373839...56

Need Help? Contact our team!


We'll reach out to this number within 24 hrs